Details of the Drug

General Information of Drug (ID: DMOI00X)

Drug Name

Ozuriftamab vedotin

Synonyms

BA3021

Indication

Disease Entry	ICD 11	Status	REF
Head-neck squamous cell carcinoma	2D60.0	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Antibody drug conjugate

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Neurotrophic tyrosine kinase ROR2 (ROR2)	TTUDPCI	ROR2_HUMAN	Inhibitor	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT05271604) A Phase 2 Open-Label Study of Ozuriftamab Vedotin (BA3021) in PD-1/L1 Failure Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck. U.S.National Institutes of Health.
2	Clinical pipeline report, company report or official report of BioAtla